NCT05812027 2025-11-17
A Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid Tumors
TScan Therapeutics, Inc.
Active not recruiting
Clinical Trials
11 trialsNCT04969419 2025-01-14
Incidence of Melanoma and Non-melanoma Skin Cancer in People With Vitiligo
Momentum Data
Completed
NCT06690086 2024-12-09
DERM-SUCCESS
DermaSensor, Inc.
Completed
NCT05929547 2023-07-03
Patient Perspectives in Squamous Cell Carcinoma Clinical Trials
Power Life Sciences Inc.
Not yet recruiting
NCT05126173 2023-06-28
DERM US and EU Validation Study
Skin Analytics Limited
Completed
NCT01077817 2022-02-03
Observational Study of Incidence Rates of Esophageal Cancer in Women Taking Medications for the Prevention or Treatment of Osteoporosis (MK-0217A-352)
Organon and Co
Completed
NCT03896958 2020-12-04
PIONEER
SpeciCare
Unknown
NCT01142869 2017-05-08
An Observational Study to Evaluate the Safety and Efficacy of Cetuximab in Combination With Platinum-based Chemotherapy in the First-line Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck
Merck KGaA, Darmstadt, Germany
Terminated
NCT02943044 2017-03-03
Quantitative Optical Sensor Findings in Head & Neck Squamous Cell Carcinoma
Zenalux Biomedical, Inc.
Unknown
NCT01075841 2014-07-02
A Post-marketing Surveillance Study on Erbitux in Combination With Platinum-based Chemotherapy in Metastatic/Recurrent Squamous Cell Cancer of the Head and Neck
Merck KGaA, Darmstadt, Germany
Withdrawn
NCT00195299 2007-12-27
Study Evaluating Temsirolimus in Advanced Stage Squamous Cell Carcinoma of the Head & Neck
Wyeth is now a wholly owned subsidiary of Pfizer
Completed